Antifungal activity of the biphosphinic cyclopalladate C7a against Candida albicans yeast forms in vitro and in vivo

Keyphrases

• Fluconazole 100%
• Candida Albicans (C. albicans) 100%
• Antifungal Activity 100%
• Yeast Form 100%
• Cyclopalladated 100%
• In Vivo Model 33%
• Morphological Changes 33%
• Minimum Inhibitory Concentration 33%
• Candida 33%
• Miconazole 33%
• Biofilm Formation 33%
• Vulvovaginal Candidiasis 33%
• Multidrug-resistant 33%
• Amphotericin B 33%
• Therapeutic Potential 33%
• Cell Wall 33%
• Fungal Burden 33%
• Vaginal Canal 33%
• Transmission Electron Microscopy 33%
• Novel Therapeutics 33%
• Drug Use 33%
• Cellular Structure 33%
• Disseminated Candidiasis 33%
• Invasive Candidiasis 33%
• Candida Isolates 33%
• New Therapeutics 33%
• Marginalization 33%
• Azole Antifungals 33%
• Yeast Cells 33%
• C.albicans 33%
• Clinical Problems 33%
• Vacuole 33%
• Chromatin 33%
• Fluorescence Microscopy 33%
• Hyphae 33%
• Number of Electrons 33%
• Minimum Fungicidal Concentration 33%
• Mitochondrial Swelling 33%
• Pseudohyphae 33%
• Fungicidal Activity 33%
• In Vivo Assay 33%
• Mature Biofilm 33%
• Non-albicans Candida 33%
• Conventional Drugs 33%
• Kidney Infection 33%
• Vaginal Candidiasis 33%
• Cellular Organelles 33%
• Lucent 33%

Immunology and Microbiology

• Candida albicans 100%
• Antifungal Activity 100%
• In Vitro 100%
• Infectious Disease 50%
• Biofilm 50%
• Candida 50%
• Infection 50%
• Minimum Inhibitory Concentration 25%
• Morphology 25%
• Cell Wall 25%
• Transmission Electron Microscopy 25%
• Yeast Cell 25%
• Fluorescence Microscopy 25%
• Hypha 25%
• Mitochondrion Swelling 25%
• Pseudohyphae 25%
• Minimum Fungicidal Concentration 25%
• Fungicidal Activity 25%
• Chromatin 25%